Savara (SVRA) Net Equity Issued and Repurchased (2011 - 2019)

Savara's (SVRA) quarterly Net Equity Issued and Repurchased came in at $1000.0 in Q4 2019, down 91.67% year-on-year from $12000.0 in Q4 2018, and down 99.98% on a QoQ basis from $5.7 million in Q3 2019.

Savara (SVRA) Net Equity Issued and Repurchased (2011 - 2019) Analysis & Trends

Savara (SVRA) has 8 years of Net Equity Issued and Repurchased data on file, last reported at $1000.0 in Q4 2019.

  • On a quarterly basis, Net Equity Issued and Repurchased fell 91.67% year-over-year to $1000.0 in Q4 2019; TTM through Dec 2020 was $5.7 million, a 80.86% decrease from a year earlier, with the FY2024 full-year figure at $24.4 million, up 177.27% from the prior year.
  • Net Equity Issued and Repurchased for Q4 2019 stood at $1000.0, down from $5.7 million in the prior quarter.
  • Over the last five years, Net Equity Issued and Repurchased for SVRA reached as high as $19.0 million in Q2 2019 and fell as low as -$7.3 million in Q2 2016.
  • Historically, Net Equity Issued and Repurchased has averaged $3.1 million across 5 years, with a median of $675000.0 in 2017.
  • On a YoY basis, Net Equity Issued and Repurchased climbed as much as 89455.56% in 2016 and fell as far as 441.81% in 2016.
  • Year by year, Net Equity Issued and Repurchased stood at $6.6 million in 2015, then sank by 99.91% to $6000.0 in 2016, then surged by 11150.0% to $675000.0 in 2017, then plunged by 98.22% to $12000.0 in 2018, then sank by 91.67% to $1000.0 in 2019.
  • Per Business Quant data, the three most recent Net Equity Issued and Repurchased figures were $1000.0 in Q4 2019, $5.7 million in Q3 2019, and $19.0 million in Q2 2019.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued and Repurchased (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn -
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 163.10 Mn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - 141.90 Mn
10 Savara 1.24 Bn 1.24 Bn - -

Historic Data

Download Data
DateValue
Dec 31, 2019 1,000.00
Dec 31, 2019 1,000.00
Sep 30, 2019 5.66 Mn
Sep 30, 2019 5.66 Mn
Jun 30, 2019 19.04 Mn
Jun 30, 2019 19.04 Mn
Mar 31, 2019 4.89 Mn
Mar 31, 2019 4.89 Mn
Dec 31, 2018 12,000.00
Dec 31, 2018 12,000.00
Mar 31, 2018 493,000.00
Mar 31, 2018 493,000.00
Dec 31, 2017 675,000.00
Dec 31, 2017 675,000.00
Sep 30, 2016 6,000.00
Sep 30, 2016 6,000.00
Jun 30, 2016 -7.28 Mn
Jun 30, 2016 -7.28 Mn
Mar 31, 2016 8.06 Mn
Mar 31, 2016 8.06 Mn